REQUEST A DEMO
Total
USD $0.00
Search more companies

Osmed Formulations Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Osmed Formulations Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Osmed Formulations Private Limited is based in India, with the head office in Ujjain. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on September 08, 1999. There was a net sales revenue increase of 61.17% reported in Osmed Formulations Private Limited’s latest financial highlights for 2025. Its’ total assets recorded a growth of 6.64%. In, 2025, the company’s net profit margin decreased by 2.69%.

Legal Address
56-57, Indudtrial Area, Maxi Road
Ujjain; Madhya Pradesh; Postal Code: 456010

Contact Details: Purchase the Osmed Formulations Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Osmed Formulations Private Limited report to view the information.
Financial Auditors:
Purchase the Osmed Formulations Private Limited report to view the information.
Incorporation Date:
September 08, 1999
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
3.01%
Company Performance
Financial values in the chart are available after Osmed Formulations Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
61.17%
Total Operating Revenue
60.79%
Operating Profit
16.21%
EBITDA
13.14%
Net Profit/Loss for the Period
21.27%
Total Assets
6.64%
Total Equity
15.88%
Operating Profit Margin
-4.87%
Net Profit Margin
-2.69%
Return on Equity (ROE)
0.6%
Debt / Equity
-16.04%
Quick Ratio
0.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?